Minister for Large and Medium Industries MB Patil said the announcement followed suggestions from industry leaders, who noted that Karnataka’s strong pharmaceutical ecosystem enables the State to compete not only with neighbouring states but also with China.
Published Nov 17, 2025 | 10:30 PM ⚊ Updated Nov 17, 2025 | 10:30 PM
Minister for Large and Medium Industries MB Patil.
Synopsis: Karnataka will seek the Centre’s approval to establish a NIPER within the proposed 5,800-acre KWIN City on Bengaluru’s north-western outskirts, Minister for Large and Medium Industries MB Patil said on Monday. Patil said the State was ready to allocate land for the institute and highlighted broader efforts to attract investment, including large land parcels along key industrial corridors and incentives for pharmaceutical companies setting up units in the State.
Karnataka will formally request the Union Government to sanction a National Institute of Pharmaceutical Sciences Education and Research (NIPER) in the proposed KWIN City, Minister for Large and Medium Industries MB Patil said on Monday, 17 November.
Unveiled in September last year, KWIN City is a 5,800-acre project that aims to host global educational and medical campuses, research centres, and healthcare facilities. It will be located between the towns of Dabaspet and Doddaballapur, on the north-western periphery of Bengaluru.
He said the State Government was prepared to allocate land for the institute and would follow up the letter with further discussions.
Patil was speaking at a round-table meeting with heads of pharmaceutical and biotech manufacturing companies at a private hotel in Bengaluru.
The Minister said the announcement followed suggestions from industry leaders, who noted that Karnataka’s strong pharmaceutical ecosystem enables the State to compete not only with neighbouring states but also with China.
Responding to their feedback, he assured companies that the government would provide all necessary support to investors.
Patil informed industry representatives that large land parcels were available along the Chennai–Bengaluru Industrial Corridor: 360 acres in Tumakuru, 850 acres in Mulavada (Phase I and II), 763 acres in Kadachuru in Yadgiri district, and 764 acres in Yadgurki in Chitradurga district.
Additionally, 1,000 acres each had been earmarked for pharmaceutical parks in Srinivaspura (Kolara) and Chamarajanagara. He encouraged companies to invest and establish manufacturing units in these locations.
“The companies investing outside Bengaluru would receive attractive incentive packages. The officials have been instructed to permit residential and school facilities within CA sites in industrial areas,” the Minister said, responding to industrialists’ concerns over gaps such as housing, schools, hotels and proper access roads in certain areas.
“The Government is also exploring educational infrastructure on the lines of the C-CAMP model. Staff have been trained to issue approvals quickly under the single-window clearance system. These improvements would be visible within the next six months.”
The Minister further said that pharmaceutical manufacturing must adopt AI-driven approaches, and that continuous skill development and uninterrupted research were essential.
He also recommended that the pharma industry convene a meeting every six months to keep pace with new technologies and trends.
Patil pointed to cost advantages in the State, noting that industries in Karnataka pay only ₹50 per kilolitre of water, compared with ₹120 in neighbouring states. To further reduce operational costs, he advised companies in industrial areas to set up common effluent treatment plants instead of maintaining individual units.
